Standard BioTools Inc.

NASDAQ: LAB · Real-Time Price · USD
1.20
-0.02 (-1.64%)
At close: Aug 15, 2025, 9:56 AM

Standard BioTools Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
166.73M 51.7M 81.31M 28.45M
Short-Term Investments
126.15M 63.19M 84.47M n/a
Long-Term Investments
2.1M 800K 1M 1M
Other Long-Term Assets
22.73M 1.48M 3.11M 3.69M
Receivables
33.61M 19.66M 17.28M 18.32M
Inventory
40.74M 20.53M 21.47M 20.82M
Other Current Assets
8.66M 3.13M 4.28M 16K
Total Current Assets
375.88M 158.22M 208.81M 72.07M
Property-Plant & Equipment
71.38M 54.85M 59.53M 65.15M
Goodwill & Intangibles
140.25M 107.72M 118.85M 134.31M
Total Long-Term Assets
236.46M 164.85M 181.5M 203.15M
Total Assets
612.34M 323.07M 390.31M 275.21M
Account Payables
12.28M 9.24M 7.91M 10.6M
Deferred Revenue
18.59M 11.61M 14.44M 15.48M
Short-Term Debt
6.23M 59.53M 2.08M 6.84M
Other Current Liabilities
10.06M 13.66M 7.81M 8.67M
Total Current Liabilities
65.89M 109.33M 43.44M 49.57M
Long-Term Debt
299K 3.98M 62.81M 64.21M
Other Long-Term Liabilities
6.96M 1.06M 961K 882K
Total Long-Term Liabilities
74.73M 50.54M 117.08M 131.05M
Total Liabilities
140.62M 159.87M 471.78M 180.62M
Total Debt
33M 98.21M 102.66M 111.65M
Common Stock
396K 83K 80K 77K
Retained Earnings
-1.19B -1B -926.1M -736M
Comprehensive Income
1.23M -2.22M -1.9M -907K
Shareholders Equity
471.72M 163.2M 229.79M 94.6M
Total Investments
126.15M 63.19M 84.47M 1M